Mapping of Target Regions of Allelic Loss in Primary Breast Cancers to 1-cM Intervals on Genomic Contigs at 6q21 and 6q25.3

Overview

Journal Jpn J Cancer Res

Specialty Oncology

Date 2000 Apr 13

PMID 10760688

Citations 10

Authors

Y Utada

S Haga

T Kajiwara

F Kasumi

G Sakamoto

Y Nakamura

M Emi

Affiliations

Soon will be listed here.

Abstract

Allelic losses on the long arm of human chromosome 6 are frequently observed in cancers of the ovary, prostate, and breast. To identify the locations of putative tumor suppressor genes on 6q, we examined 192 primary breast cancers for patterns of allelic loss at 16 polymorphic microsatellite loci distributed along this chromosome arm. Allelic losses at one or more loci were observed in 105 (55%) of the tumors examined. Detailed deletion mapping with appropriate yeast artificial chromosome (YAC) contigs identified two distinct commonly deleted regions; one was confined to a 1-cM interval at 6q21 flanked by D6S1040 and D6S262 and the other to a 1-cM interval at 6q25.3 flanked by D6S305 and D6S411. Allelic losses at 6q21 were more frequent in invasive solid tubular and scirrhous carcinomas than in tumors of less aggressive histologic types (P = 0.0006). Allelic loss at 6q25.3 was associated with loss of progesterone receptor (P = 0.0256). Our results suggest the presence of two tumor suppressor genes for breast cancer on 6q that are likely to be associated with tumor progression and / or loss of hormonal dependency.

Citing Articles

Chromosomal Location of Genes Differentially Expressed in Tumor Cells Surviving High-Dose X-ray Irradiation: A Preliminary Study on Radio-Fragile Sites.

Tsutsumi K, Masuda M, Date H Curr Issues Mol Biol. 2021; 43(2):1133-1141.

PMID: 34563049 PMC: 8929007. DOI: 10.3390/cimb43020080.

Cyclin C is a haploinsufficient tumour suppressor.

Li N, Fassl A, Chick J, Inuzuka H, Li X, Mansour M Nat Cell Biol. 2014; 16(11):1080-91.

PMID: 25344755 PMC: 4235773. DOI: 10.1038/ncb3046.

BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma.

Williams C, Zhang B, Smith J, Jayagopal A, Barrett C, Pino C J Clin Invest. 2011; 121(10):4056-69.

PMID: 21911938 PMC: 3195453. DOI: 10.1172/JCI44228.

Candidate genes and potential targets for therapeutics in Wilms' tumour.

Blackmore C, Coppes M, Narendran A Clin Transl Oncol. 2010; 12(9):597-605.

PMID: 20851800 DOI: 10.1007/s12094-010-0564-y.

Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.

Chan T, Glockner S, Yi J, Chen W, Van Neste L, Cope L PLoS Med. 2008; 5(5):e114.

PMID: 18507500 PMC: 2429944. DOI: 10.1371/journal.pmed.0050114.

References

Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y . Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res. 1991; 51(21):5794-9. View

Ito I, Yoshimoto M, Iwase T, Watanabe S, Katagiri T, Harada Y . Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer. 1995; 71(3):438-41. PMC: 2033649. DOI: 10.1038/bjc.1995.89. View

Sherratt T, Morelli C, Boyle J, Harrison C . Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21. Chromosome Res. 1997; 5(2):118-24. DOI: 10.1023/a:1018418224660. View

Chappell S, Walsh T, Walker R, Shaw J . Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Br J Cancer. 1997; 75(9):1324-9. PMC: 2228245. DOI: 10.1038/bjc.1997.224. View

Queimado L, Seruca R, Costa-Pereira A, Castedo S . Identification of two distinct regions of deletion at 6q in gastric carcinoma. Genes Chromosomes Cancer. 1995; 14(1):28-34. DOI: 10.1002/gcc.2870140106. View

Harada Y, Katagiri T, Ito I, Akiyama F, Sakamoto G, Kasumi F . Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations. Cancer. 1994; 74(8):2281-6. DOI: 10.1002/1097-0142(19941015)74:8<2281::aid-cncr2820740812>3.0.co;2-i. View

Cooney K, Wetzel J, Consolino C, Wojno K . Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res. 1996; 56(18):4150-3. View

Laureys G, Barton D, Ullrich A, Francke U . Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-independent mannose 6-phosphate receptor in man and mouse. Genomics. 1988; 3(3):224-9. DOI: 10.1016/0888-7543(88)90083-3. View

Takeuchi S, Koike M, Seriu T, Bartram C, Schrappe M, Reiter A . Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res. 1998; 58(12):2618-23. View

10.

Iwase H, Greenman J, Barnes D, Bobrow L, Hodgson S, Mathew C . Loss of heterozygosity of the oestrogen receptor gene in breast cancer. Br J Cancer. 1995; 71(3):448-50. PMC: 2033633. DOI: 10.1038/bjc.1995.91. View

11.

Cooke I, Shelling A, Le Meuth V, Charnock M, Ganesan T . Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Genes Chromosomes Cancer. 1996; 15(4):223-33. DOI: 10.1002/(SICI)1098-2264(199604)15:4<223::AID-GCC4>3.0.CO;2-3. View

12.

Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A . A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 1996; 380(6570):152-4. DOI: 10.1038/380152a0. View

13.

Fujii H, Zhou W, Gabrielson E . Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues. Genes Chromosomes Cancer. 1996; 16(1):35-9. DOI: 10.1002/(SICI)1098-2264(199605)16:1<35::AID-GCC5>3.0.CO;2-4. View

14.

Yokota T, Matsumoto S, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G . Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21. Jpn J Cancer Res. 1998; 88(10):959-64. PMC: 5921283. DOI: 10.1111/j.1349-7006.1997.tb00315.x. View

15.

Menasce L, White G, Harrison C, Boyle J . Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics. 1993; 17(1):263-5. DOI: 10.1006/geno.1993.1320. View

16.

Sheng Z, Marchetti A, Buttitta F, Champeme M, Campani D, Bistocchi M . Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer. 1996; 73(2):144-7. PMC: 2074311. DOI: 10.1038/bjc.1996.27. View

17.

Noviello C, Courjal F, Theillet C . Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. Clin Cancer Res. 1996; 2(9):1601-6. View

18.

Iida A, Kurose K, Isobe R, Akiyama F, Sakamoto G, Yoshimoto M . Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer. 1998; 21(2):108-12. View

19.

Theile M, Seitz S, Arnold W, Jandrig B, Frege R, Schlag P . A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene. 1996; 13(4):677-85. View

20.

. The general rules for clinical and pathological recording of breast cancer. Japanese Breast Cancer Society. Jpn J Surg. 1989; 19(5):612-32. DOI: 10.1007/BF02471672. View